Vabametkib

Modify Date: 2024-04-06 19:17:00

Vabametkib structure	Common Name	Vabametkib
	CAS Number	1571903-56-4	Molecular Weight	566.66
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₉H₃₄N₁₂O	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Vabametkib

Vabametkib is a potent inhibitor of hepatocyte growth factor receptor (HGFR). Vabametkib inhibits Hs746T cells proliferation and inhibits c-Met with an IC50 value of 7 nM. Vabametkib can be used as an antineoplastic agent[1][2].

Name	Vabametkib

Description	Vabametkib is a potent inhibitor of hepatocyte growth factor receptor (HGFR). Vabametkib inhibits Hs746T cells proliferation and inhibits c-Met with an IC50 value of 7 nM. Vabametkib can be used as an antineoplastic agent[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Met/HGFR
References	[1]. WHO Drug Informat ion - World Health Organization (WHO). [2]. Jung Hui Jeong, et al. Preparation of triazolopyrazine derivatives as c-Met kinase inhibitors: Korea, Republic of, KR2014022229. 2014-02-24. [3]. WHO Drug Information-World Health Organization (WHO).

Description

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Met/HGFR

References

[1]. WHO Drug Informat ion - World Health Organization (WHO).

[2]. Jung Hui Jeong, et al. Preparation of triazolopyrazine derivatives as c-Met kinase inhibitors: Korea, Republic of, KR2014022229. 2014-02-24.

[3]. WHO Drug Information-World Health Organization (WHO).